Ads
related to: Dupixent Eczema- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Patient Support
Hear From The Ambassadors—
How This Treatment Option Works
- Home
Official Patient Website—
Get Treatment Info Today.
- Sign Up
Apply Or Activate Your Card—
Find Out If You're Eligible Today.
- Treatment Support
Discover Educational Resources
& Get Financial Support Information
- Support Resources
Sign Up And Learn More About The
Patient Education Program Today.
- FAQs
Search results
Sanofi's Dupixent gets U.S. approval to treat eczema in young children
Reuters via Yahoo News· 2 years agoDupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...
Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids
Zacks via Yahoo Finance· 1 year agoSanofi (SNY) and Regeneron's Dupixent becomes the first and only targeted medicine approved to treat...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 1 week agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Danielle Jonas says her eczema affected her self-esteem and deterred her from going on tour often...
INSIDER via Yahoo News· 9 months agoDanielle Jonas opened up about her eczema journey in a recent interview with Insider.Courtesy of...
Treatments for Eczema
Health via Yahoo News· 7 months agoEczema (also known as dermatitis) is a condition that primarily affects the skin, causing dryness, itchiness, scaliness, rashes, and blisters. In some...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 1 week agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 6 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Zacks via Yahoo Finance· 2 months agoASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...
How to manage eczema – according to a dermatologist
The Telegraph via Yahoo News· 3 months agoThe condition can be uncomfortable and create a sense of social embarrassment among sufferers For the one in 10 adults who will develop eczema at some...
Eczema and the COVID-19 Vaccine: Is it Safe?
Verywell Health via Yahoo News· 2 years agoCOVID-19 vaccines are safe for people who have eczema, an itchy rash that is the most common type of atopic dermatitis. The COVID-19 vaccines available...
Ads
related to: Dupixent Eczema